| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1074248414559838 |
| P698 | PubMed publication ID | 25432872 |
| P50 | author | James C Coons | Q60318135 |
| P2093 | author name string | Jacob C Jentzer | |
| Christopher B Link | |||
| Mark Schmidhofer | |||
| P2860 | cites work | Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials | Q21195136 |
| ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) | Q22242892 | ||
| Comparison of Dopamine and Norepinephrine in the Treatment of Shock | Q22250880 | ||
| Systemic Steroids in Severe Sepsis and Septic Shock | Q22306309 | ||
| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 | Q28284276 | ||
| The clinical implications of isolated alpha(1) adrenergic stimulation | Q30453315 | ||
| Pharmacodynamic effects of milrinone with and without a bolus loading infusion | Q31928175 | ||
| Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. | Q33213688 | ||
| Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension | Q34153303 | ||
| Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. | Q34228515 | ||
| The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series | Q34340908 | ||
| Vasopressin versus norepinephrine infusion in patients with septic shock. | Q34756330 | ||
| The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis | Q34971810 | ||
| The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications | Q35010370 | ||
| Causes of death and determinants of outcome in critically ill patients | Q35629826 | ||
| Effects of changes in arterial pressure on organ perfusion during septic shock | Q35908154 | ||
| Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study | Q46966848 | ||
| The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock | Q47879474 | ||
| Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. | Q50898825 | ||
| Images in cardiovascular medicine. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. | Q51411774 | ||
| The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. | Q51508414 | ||
| Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. | Q51655030 | ||
| Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery | Q51681506 | ||
| Enoximone treatment of impaired myocardial function during cardiac surgery: combined effects with epinephrine. | Q51729766 | ||
| Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). | Q53344976 | ||
| The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients. | Q53897598 | ||
| The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. | Q54191284 | ||
| Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? | Q54238540 | ||
| Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. | Q54516570 | ||
| Comparison of dopamine and dobutamine following coronary artery bypass grafting. | Q54524641 | ||
| Circulatory Shock | Q56137044 | ||
| High versus Low Blood-Pressure Target in Patients with Septic Shock | Q57016679 | ||
| The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: A propensity score and instrumental variable analysis using the Acutely Decompensated H | Q57630931 | ||
| Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial | Q57778873 | ||
| Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines | Q57778967 | ||
| Bench-to-bedside review: Vasopressin in the management of septic shock | Q36070556 | ||
| Use of inotropes and vasopressor agents in critically ill patients. | Q36147248 | ||
| Survival after shock requiring high-dose vasopressor therapy | Q36664389 | ||
| Inotropes in the management of acute heart failure | Q37044857 | ||
| Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. | Q37105993 | ||
| Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study | Q37360357 | ||
| Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress | Q37585835 | ||
| Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial | Q37603555 | ||
| Vasoactive drugs in circulatory shock | Q37811626 | ||
| Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis | Q37962808 | ||
| Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials | Q37967364 | ||
| Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial | Q39212581 | ||
| The effect of vasopressin on the hemodynamics in CABG patients | Q39371412 | ||
| The pressor dose-response in clinical cardiovascular pharmacology | Q39657822 | ||
| Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure | Q40744817 | ||
| Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock | Q41189097 | ||
| Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy | Q41457809 | ||
| Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients | Q41700779 | ||
| Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock | Q41992933 | ||
| Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | Q42220333 | ||
| Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? | Q42601060 | ||
| Intraaortic balloon support for myocardial infarction with cardiogenic shock | Q42664790 | ||
| Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study | Q42841240 | ||
| Efficacy and safety of dopamine versus norepinephrine in the management of septic shock | Q43256319 | ||
| The effects of vasopressin on acute kidney injury in septic shock. | Q43258485 | ||
| Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial | Q43276181 | ||
| Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial | Q43412778 | ||
| Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery | Q43653626 | ||
| Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact | Q43805510 | ||
| Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol | Q43823417 | ||
| Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial | Q43930568 | ||
| Heart rate-right ventricular stroke volume relation with myocardial revascularization | Q44057055 | ||
| Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol | Q44182274 | ||
| Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial | Q44321715 | ||
| Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study | Q44371716 | ||
| Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study | Q44430966 | ||
| Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock | Q44867475 | ||
| Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure | Q44931781 | ||
| Association between inotrope treatment and 90-day mortality in patients with septic shock | Q45075848 | ||
| Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. | Q46111974 | ||
| The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study | Q46416686 | ||
| Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function | Q46428102 | ||
| Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group | Q46447251 | ||
| A comparison of epinephrine and norepinephrine in critically ill patients | Q46463165 | ||
| In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). | Q46578814 | ||
| Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study | Q46744325 | ||
| Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock | Q46944278 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacotherapy | Q701216 |
| intensive care unit | Q5094647 | ||
| P304 | page(s) | 249-260 | |
| P577 | publication date | 2014-11-28 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology and Therapeutics | Q1855644 |
| P1476 | title | Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit | |
| P478 | volume | 20 |
| Q64951310 | Angiotensin II: a new therapeutic option for vasodilatory shock. |
| Q59812804 | Development and performance of a novel vasopressor-driven mortality prediction model in septic shock |
| Q90265411 | Dopamine in critically ill patients with cardiac dysfunction: A systematic review with meta-analysis and trial sequential analysis |
| Q40895857 | Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study protocol for randomized controlled trial |
| Q41009669 | Impact of New-Onset Left Ventricular Dysfunction on Outcomes in Mechanically Ventilated Patients With Severe Sepsis and Septic Shock |
| Q90435830 | Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock |
| Q91841513 | Management of Cardiogenic Shock in a Cardiac Intensive Care Unit |
| Q46072211 | Milrinone role in treatment of septic shock |
| Q58567991 | Paradoxical reflex bradycardia after epinephrine infusion for arrhythmia induction in the electrophysiology laboratory |
| Q49927372 | Risk Factors of Vasopressor-Induced Symmetrical Peripheral Gangrene |
| Q55041662 | Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure. |
| Q90446344 | Shock - Classification and Pathophysiological Principles of Therapeutics |
| Q28068818 | Vasoactive agents for the treatment of sepsis |
| Q52821448 | [Acute and chronic heart failure]. |
Search more.